Testosterone

BreastfeedingPediatric
  • TRADE NAMES: Andro LA; Androderm (Actavis); AndroGel (AbbVie); Andronaq; Delatest; Delatestryl (Endo); Duratest; Fortesta (Endo); Natesto (Endo); Testandro; Testim (Auxilium); Testoderm; Testopel; Testopel
  • INDICATIONS: Androgen replacement; hypogonadism, postpartum breast pain
  • CLASS: Androgen
  • HALF-LIFE: 10–100 minutes
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Acarbose, Anisindione, Anticoagulants, Cyclosporine, Dicumarol, Metformin, Saxagliptin, Sitagliptin, Warfarin

PREGNANCY CATEGORY: N/A
Contra-indicated in pregnancy

NOTE

Contra-indicated in men with carcinoma of the breast or known or suspected carcinoma of the prostate.

BLACK BOX WARNING
SECONDARY EXPOSURE TO TESTOSTERONE

See full prescribing information for complete boxed warning.

Our database has 65 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
OCULAR.
RESPIRATORY.
OTHER.


Page last updated 07/31/2023

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top